{{Drugbox
| verifiedrevid =  
| IUPAC_name = 4,5-bis(4-methoxyphenyl)-2-(trifluoromethyl)-1H-imidazole
| image = Flumizole structure.svg
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  
<!--Identifiers-->
| CAS_number = 36740-73-5
| ATC_prefix = none
| PubChem = 37518
| DrugBank =  
| ChemSpiderID = 34419
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Y4YQF944N9
| KEGG = D04211
| ChEMBL = 430150
| synonyms =  
<!--Chemical data-->
| C=18 | H=15 | F=3 | N=2 | O=2
| molecular_weight = 348.32 g/mol
| smiles = FC(F)(F)c2nc(c(c1ccc(OC)cc1)n2)c3ccc(OC)cc3
| StdInChI=1S/C18H15F3N2O2/c1-24-13-7-3-11(4-8-13)15-16(23-17(22-15)18(19,20)21)12-5-9-14(25-2)10-6-12/h3-10H,1-2H3,(H,22,23)
| StdInChIKey = OPYFPDBMMYUPME-UHFFFAOYSA-N
}}

'''Flumizole''' is an [[antiinflammatory]] agent. More specifically, it is a [[nonsteroidal anti-inflammatory drug]] (NSAID) that acts via inhibition of the enzyme [[cyclooxygenase]] (COX).<ref>{{Cite journal 
| doi = 10.1002/jps.2600640909 
| last1 = Wiseman | first1 = E. H. 
| last2 = McIlhenny | first2 = H. M. 
| last3 = Bettis | first3 = J. W. 
| title = Flumizole, a new nonsteroidal anti-inflammatory agent 
| journal = Journal of pharmaceutical sciences 
| volume = 64 
| issue = 9 
| pages = 1469â€“1475 
| year = 1975 
| pmid = 810570
}}</ref>

==References==
{{Reflist|2}}


{{Anti-inflammatory and antirheumatic products}}
{{Analgesics}}
{{Prostanoidergics}}

[[Category:Analgesics]]
[[Category:COX-2 inhibitors]]
[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Imidazoles]]
[[Category:Trifluoromethyl compounds]]
[[Category:Phenol ethers]]


{{musculoskeletal-drug-stub}}